Keyphrases
Hong Kong
100%
Enterobacteriaceae
100%
Temocillin
100%
Fosfomycin
100%
Colistin
100%
Minimum Inhibitory Concentration
50%
British Society
37%
Extended-spectrum β-lactamase
37%
Antimicrobial Chemotherapy
37%
Escherichia Coli
25%
Ciprofloxacin
25%
Meropenem
25%
Klebsiella
25%
Nitrofurantoin
25%
Piperacillin-tazobactam
25%
Resistance Rate
25%
Gentamicin
12%
Antimicrobial
12%
Antimicrobial Resistance
12%
In Vitro Activity
12%
MIC90
12%
Clinically Significant
12%
Agar Dilution
12%
Infection Treatment
12%
Ceftazidime
12%
Cefepime
12%
Ceftriaxone
12%
Public Hospitals
12%
Amikacin
12%
Ertapenem
12%
Tigecycline
12%
Asian Countries
12%
Amoxicillin-clavulanate
12%
Proteus
12%
MIC50
12%
Clinical Standards
12%
Laboratory Standards
12%
Trimethoprim-sulfamethoxazole (TMP-SMX)
12%
KPC-2
12%
Hospital Authority
12%
NDM-5
12%
Positivity Rate
12%
Significant Bacteriuria
12%
Multidrug-resistant Enterobacteriaceae
12%
Microbroth Dilution
12%
Microbroth Dilution Method
12%
Susceptibility Rate
12%
Pharmacology, Toxicology and Pharmaceutical Science
Enterobacteriaceae
100%
Temocillin
100%
Colistimethate
100%
Fosfomycin
100%
Minimum Inhibitory Concentration
50%
Antiinfective Agent
37%
Chemotherapy
37%
Extended Spectrum Beta Lactamase
37%
Escherichia coli
25%
Ciprofloxacin
25%
Klebsiella
25%
Meropenem
25%
Piperacillin Plus Tazobactam
25%
Nitrofurantoin
25%
Gentamicin
12%
Infection
12%
Amoxicillin
12%
Clavulanic Acid
12%
Amikacin
12%
Agar Dilution
12%
Ceftazidime
12%
Ceftriaxone
12%
Antimicrobial Resistance
12%
Tigecycline
12%
Ertapenem
12%
Bacteriuria
12%
Cefepime
12%
Cotrimoxazole
12%
Immunology and Microbiology
Enterobacteriaceae
100%
Minimum Inhibitory Concentration
100%
Colistin
100%
Escherichia coli
50%
Klebsiella
50%
Broth Dilution
50%
Dilution
25%
Agar Dilution
25%
MIC50
25%
MIC90
25%
Antimicrobial Resistance
25%